Merck (d.b.a. EMD Millipore in the U.S. and Canada) is a German chemical and pharmaceutical company. Merck, also known as “German Merck” and “Merck Darmstadt”, was founded in Darmstadt, Germany, in 1668, making it the world's oldest operating chemical and pharmaceutical company. The company was privately owned until going public in 1995. However, the Merck family still controls a majority (≈70%) of the company's shares. Following World War I, Merck lost possession of its foreign sites, including the Merck & Co. subsidiary in the United States. Merck & Co., which operates as Merck Sharp and Dohme (MSD) outside the U.S. and Canada, is now an independent company. Merck KGaA operates mainly in Europe, Africa, Asia, Oceania and Latin America. Since Merck & Co. holds the rights to the Merck name in the U.S. and Canada, the company operated under the umbrella brand EMD Chemicals in North America, and since 2010 as EMD Millipore (after the acquisition of Millipore Corporation), formed from the initials of Emanuel Merck, Darmstadt. Founded in 1668 in Darmstadt, Merck KGaA of Darmstadt, Germany, is the world's oldest pharmaceutical and chemical company. The success of the export business to the United States led in 1887 to the establishment of an office in New York, which gave rise to their subsidiary [Merck & Co.](http://www.crunchbase.com/organization/merck-co-inc) four years later. Owing to World War I, Merck & Co. was expropriated in 1917. The two companies have been separate every since. Merck KGaA Subsidiaries: - [Merck Consumer Healthcare](http://www.crunchbase.com/organization/merck-consumer-healthcare) - [Merck Performance Materials](http://www.crunchbase.com/organization/merck-performance-materials)

Yeda Research and Development Company Ltd. is the commercial arm of the Weizmann Institute of Science. Yeda holds an exclusive agreement with the Weizmann Institute to commercialize the unique intellectual property developed by the scientists. The income generated serves to support further basic research and science education. - Identify and assess research projects with commercial potential. - Protect the intellectual property of the Institute and its scientists. - Create business relationships and license the Institute’s inventions and technologies to the industry. - Channel funding from industry to research projects. For further information please contact Tamir Huberman, CIO and Head of Marketing

Charles River Laboratories, Inc., is an American corporation specializing in a variety of preclinical and clinical laboratory services for the pharmaceutical, medical device and biotechnology industries. It also supplies assorted biomedical products and research and development outsourcing services for use in the pharmaceutical industry. According to its website, its customers include leading pharmaceutical, biotechnology, agrochemical, government, and academic organization around the globe.

Provides insurance brokerage services

Imperial Innovations is a technology commercialization and venture capital investor that focuses on technology. Imperial Innovations no longer invests in startups and now functions as the technology-transfer office of Imperial College. Imperial Innovations is focused on commercialising leading UK academic research sourced from the 'golden triangle' formed between Cambridge, Oxford and London. We are a technology commercialisation company that combines the activities of technology transfer, intellectual property protection and licensing, company incubation and investment. Innovations is focused on commercialising the most promising UK academic research across a broad range of technology sectors, and has developed particular expertise in: therapeutics, medtech, engineering and materials and information communication technology.

Oxford University Innovation is the University of Oxford's technology transfer company and manages the University's intellectual property portfolio, working with University researchers on identifying, protecting and marketing technologies through licensing, spin-out company formation and material sales. Oxford University Innovation also manages Oxford University Consulting, which arranges consulting services providing clients access to the expertise of the University's academics. Oxford University’s overarching Strategic Plan begins, “The University of Oxford aims to lead the world in research and education” immediately followed by, “They seek to do this in ways which benefit society on a national and a global scale.” Oxford University Innovation helps staff and students to apply their expertise and research for wider social and economic benefit. Their role is to help University staff and students bring the benefits of their research and expertise to create impact in wider society. They support Oxford’s researchers, staff and students, offering commercial skills and a range of specialist resources in order to maximise research impact. Income is shared with those involved according to the University’s Regulations.

Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA.

Phenomix Corp. is a biopharmaceutical company focused on the discovery, development and commercialization of novel small-molecule product candidates directed toward clinically validated targets in significant therapeutic markets. It's internally discovered product candidates are designed to have improved efficacy, safety or convenience relative to existing therapies and other product candidates in clinical development. Its lead product candidate, dutogliptin tartrate, is a dipeptidyl peptidase-4, or DPP-4, inhibitor that it is developing as an oral, once-daily treatment for Type 2 diabetes. Its Phase 2b clinical trial of dutogliptin demonstrated statistically significant reductions in HbA1c when administered in combination with existing drugs for the treatment of Type 2 diabetes. The company commenced its Phase 3 clinical program in the third quarter of 2008. Its second product candidate, PHX1766, is a protease inhibitor currently in Phase 1 of clinical development for the treatment of hepatitis C virus, or HCV, infection.\nThe company intends to maximize the value of its product candidates through independent development, licensing and other partnership opportunities. These may include co-development or co-marketing agreements, licensing agreements with pharmaceutical and biotechnology companies that possess established development and commercialization capabilities or direct commercialization by building its own sales and marketing force.

ZHONGHE PHARMACEUTICAL is a manufacturer of pharmaceutical products. They offer research and industrialization of chemically synthesised peptides and nucleosides. Their products include thymopentin for injection, thymopentin injection, heyi-eptifibatide injection, thymopentin injection, thymus fasin for injection, somatostatin for injection, and heqi-octreotide acetate injection.

Cheng Du Tian Tai Shan Zhi Yao Gu Fen You Xian Gong Si, established on 2000-09-29, Business scope includes licensed projects:pharmaceutical production;Drug retail;Drug import and export;road freight transport(Does not contain dangerous goods);Drug Wholesale;Pharmaceutical commissioned production.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Production of Chinese herbal extracts;Packaging special equipment manufacturing;Technology Import and Export;Chinese herbal medicine planting;real estate herbal medicine(Does not contain Chinese herbal medicine)buy and sell;Medical Research and Experimental Development;Specialty Chemicals Sales(Free of Hazardous Chemicals);Import and export;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;business management;Business Management Consulting;Commercial Complex Management Services.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA.

Harlan Laboratories, Inc. provided essential, pre-clinical and non-clinical contract research, research models, lab animal diets and services. The firm's focused on providing customers with products and services to optimize the discovery and safety of new medicines and compounds. The company was founded in 1931 and was headquartered in Indianapolis, IN.

Hubei Meilin Pharmaceutical Co., Ltd., established on 2010-04-12, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Health food production;Drug import and export;Import of new chemical substances;Drug Wholesale;Veterinary drug business;The second type of monitoring chemical management;The first category of non-pharmaceutical precursor chemicals business;medical service(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Manufacturing of basic chemical raw materials(Manufacture of licensed chemicals free of hazardous chemicals);Chemical product production(No licensed chemical products);Manufacturing of daily chemical products;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Healthy food(prepackaged)Sales;Cosmetics Wholesale;Disinfectant sales(Free of Hazardous Chemicals);Specialty Chemicals Sales(Free of Hazardous Chemicals);Technology Import and Export;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Tulane Educational Fund is a private company headquartered in the United States specializing in radio broadcasting stations.

Beijing Yuanyan Pharmaceutical Technology Co., Ltd. is a Chinese private company located in Beijing that offers information technology services.

Hubei Jisheng Pharmaceutical Co., Ltd., established on 2008-12-10, Business scope includes Chinese patent medicine,Chemical API,Chemicals,Antibiotic API,antibiotic preparation,biochemical drug,Anabolics,peptide hormone(Does not contain refrigerated and frozen medicines)wholesale;the first sort,second category,Wholesale of Class III Medical Devices;food business;Wholesale of primary agricultural products,retail;glassware,Glasses,Daily necessities,Family Planning Supplies,Disinfectant,Health Products Wholesale;Import and export of goods and technology(Does not contain goods and technologies restricted or prohibited by the state);Biological product,Health products,food,medicine,medical instruments,R&D of hygiene products,technical consulting;account Serive;Warehousing Services;Medical information consultation(Does not contain internet drugs,medical instruments,Information Consulting);Medical equipment rental and maintenance(Projects subject to approval by law,Business activities can only be carried out after approval by relevant departments).